Telephone: +39-045-8027102; Fax: +39-045-8027127
Translational and Clinical Research
Version of Record online: 12 AUG 2009
Copyright © 2009 AlphaMed Press
Volume 27, Issue 10, pages 2624–2635, October 2009
How to Cite
Constantin, G., Marconi, S., Rossi, B., Angiari, S., Calderan, L., Anghileri, E., Gini, B., Dorothea Bach, S., Martinello, M., Bifari, F., Galiè, M., Turano, E., Budui, S., Sbarbati, A., Krampera, M. and Bonetti, B. (2009), Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune Encephalomyelitis. STEM CELLS, 27: 2624–2635. doi: 10.1002/stem.194
Author contributions: G.C.: Conception and design, final approval of manuscript, financial support, manuscript writing; S.M.: Data analysis and interpretation; B.R.: Data analysis and interpretation; S.A.: Data analysis and interpretation; L.C.: Data analysis and interpretation; E.A.: Data analysis and interpretation; B.G.: Data analysis and interpretation; S.D.B.: Data analysis and interpretation; M.M.: Data analysis and interpretation; F.B.: Provision of study material, collection, and/or assembly of data; M.G.: Provision of study material, collection, and/or assembly of data; E.T.: Data analysis and interpretation; S.B.: Data analysis and interpretation; A.S.: Conception and design, manuscript writing; M.K.: Conception and design, final approval of manuscript, financial support; B.B.: Conception and design, final approval of manuscript, financial support, manuscript writing.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS August 12, 2009.
- Issue online: 13 OCT 2009
- Version of Record online: 12 AUG 2009
- Accepted manuscript online: 12 AUG 2009 12:00AM EST
- Manuscript Accepted: 1 AUG 2009
- Manuscript Received: 20 MAY 2009
- National Multiple Sclerosis Society, New York, NY
- Fondazione Cariverona
- Italian Ministry of Education and Research
- Fondazione Italiana Sclerosi Multipla
- 1The neuropathology of multiple sclerosis. In: RaineCS, McFarlandH, TourtellotteW, eds. Multiple sclerosis. London, UK: Chapman & Hall Med, 1997: 149–172..
- 2A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158–164., , et al.
- 3Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278–285., , et al.
- 4Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003; 422: 688–694., , et al.
- 5Neurosphere-derived multipotent precursors promote long-lasting neuroprotection by an immunomodulatory mechanism. Nature 2005; 436: 266–271., , et al.
- 6Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393–395., , et al.
- 7Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235–242., , .
- 8Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896–904., , et al.
- 9Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211–228., , et al.
- 10Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 2005; 102: 18171–18176., , et al.
- 11Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–3729., , .
- 12Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006; 36: 2566–2573., , .
- 13Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726–736., , .
- 14Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng 2007; 13: 1185–1195., , et al.
- 15Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106: 1755–1761., , et al.
- 16Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005; 195: 16–26., , et al.
- 17Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61: 219–227., , et al.
- 18Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008; 65: 753–761., , Et al.
- 19Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57: 1192–1203., , et al.
- 20Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 2009; 182: 5994–6002., , et al.
- 21Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 2003; 89: 267–270., , et al.
- 22Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006; 24: 150–154., , et al.
- 23Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 2006; 6: 567–578., .
- 24Immunomodulatory effects of human adipose tissue-derived stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005; 129: 118–129., , et al.
- 25The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006; 24: 1246–1253., , et al.
- 26Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189: 54–63., , et al.
- 27Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 2000; 16: 759–769., , et al.
- 28Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun 2002; 294: 371–379., , et al.
- 29Characterization of neuronal/glial differentiation of murine adipose-derived adult stromal cells. Exp Neurol 2004; 187: 319–328., , et al.
- 30Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174: 101–109., , et al.
- 31Autologous adipose tissue-derived stromal cells for treatment of spinal cord injury. Stem Cells Dev 2006; 15: 583–594., , et al.
- 32The potential of adipose-derived adult stem cells as a source of neuronal progenitor cells. Plast Reconstr Surg 2005; 116: 1453–1460., , .
- 33Neural differentiation of adipose-derived stem cells isolated from GFP transgenic mice. Biochem Biophys Res Commun 2005; 333: 116–121., , et al.
- 34Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells. Differentiation 2006; 74: 510–518., , et al.
- 35Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 2007; 40: 382–390., , et al.
- 36Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. Stem Cells Dev 2008; 17: 909–916., , et al.
- 37Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor. J Immunol 1999; 162: 1144–1149., , et al.
- 38Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Methods 2006; 311: 117–125., , et al.
- 39Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol 2009; 10: 185–194., , et al.
- 40Molecular mechanisms involved in lymphocyte recruitment in brain microcirculation: critical roles for PSGL-1 and trimeric G alpha-linked receptors. J Immunol 2002; 168: 1940–1949., , et al.
- 41Transketolase and CNPase I are specifically recognized by IgG autoantibodies in multiple sclerosis patients. Mol Cell Proteomics 2008; 7: 2337–2349., , et al.
- 42An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. Proc Natl Acad Sci USA 2005; 102: 10273–10278., , et al.
- 43Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 1997; 159: 5733–5741., , et al.
- 44PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Mineral Res 2008; 23: 1519–1528., , et al.
- 45Fibroblast growth factor-2 and platelet-derived growth factor AB promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 2002; 20: 390–403., , , .
- 46Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992; 356: 63–66., , et al.
- 47In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007; 25: 220–227., , et al.
- 48Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 2006; 24: 2412–2419., , .
- 49Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin. Glia 1998; 24: 390–397., , , .
- 50Differentiation, cell fusion and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003; 100: 2397–2402., , et al.
- 51Mesenchymal stem cell as trophic mediators. J Cell Biochem 2006; 98: 1076–1084., .
- 52Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells 2006; 24: 2209–2219., , et al.
- 53In vivo actions of fibroblast growth factor 2 and insulin-like growth factor I on oligodendrocyte development and myelination in the central nervous system. J Neurosci Res 1999; 57: 74–85., , .
- 54Fibroblast growth factor 2 gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Therapy 2001; 8: 1207–1213., , et al.
- 55Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J Neuroimmunol 2009; 210: 40–51., , et al.